United States · FDA National Drug Code directory

TIAZAC EXTENDED RELEASE

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
0187-2612_d16e7ace-3d95-4196-a7b0-cdd26f3bd8e7
Product NDC
0187-2612
Form
CAPSULE, EXTENDED RELEASE
Composition / generic term
diltiazem hydrochloride
Labeler
Bausch Health US, LLC
Marketing category
NDA
Marketing start / end (source format)
20140820
Source listing expiry
20271231

Source-listed ingredients

  • DILTIAZEM HYDROCHLORIDE — 120 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0187-2612-30) · 0187-2612-30
  • 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0187-2612-90) · 0187-2612-90

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →